✦ LIBER ✦
We-W42:3 Rimonabant improves cardiometabolic risk factors in overweight/obese patients irrespective of treatment with statins: Pooled data from the RIO program
✍ Scribed by Després, J.P.; Van Gaal, L.; Scheen, A.; Pi-Sunyer, F.X.
- Book ID
- 123042952
- Publisher
- Elsevier Science
- Year
- 2006
- Tongue
- English
- Weight
- 158 KB
- Volume
- 7
- Category
- Article
- ISSN
- 1567-5688
No coin nor oath required. For personal study only.